Blog
Motorcar Parts Q1 Revenue Up 11 Percent
Motorcar Parts Of America (NASDAQ:MPAA), a supplier of replacement parts and electrical diagnostic equipment for vehicles, reported its earnings for the fiscal first quarter (ended June 30, 2025) on
ArriVent Posts Wider Loss in Fiscal Q2
ArriVent BioPharma (NASDAQ:AVBP), a clinical-stage oncology company, reported its second quarter 2025 earnings on August 11, 2025. The most important update was a wider net loss than expected--the
Up 23% to 132%, There's Still Time to Buy These 3 Stocks
We're more than halfway through 2025, and so far, it's shaping up to be another solid year for the stock market. As of this writing, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average
Do NuScale Power and Oklo Have a New Opportunity That's Out of This World?
With few exceptions, nuclear energy stocks have provided stellar returns in 2025. From new collaborations that small modular reactor (SMR) makers like NuScale Power (NYSE: SMR) and Oklo (NYSE: OKLO)
L.b. Foster Posts 51% EBITDA Jump in Q2
L.b. Foster (NASDAQ:FSTR), a key player in infrastructure and technology-driven solutions for rail and construction markets, reported earnings for Q2 2025 on August 11, 2025. The most important
US Cellular EPS Jumps 80 Percent in Q2
United States Cellular (NYSE:USM), Now solely a tower operator following the sale of its wireless operations to T-Mobile, delivered its second quarter earnings release on August 11, 2025. The
Which Four Questions Should You Ask Before Retiring in a Bear Market?
Whether you're actively planning for retirement or simply dreaming of the day you can retire, you probably have questions. For example, you may wonder how much you must save to retire in style. You
Aaon Posts 65 Percent EPS Drop in Q2
Aaon (NASDAQ:AAON), a leading manufacturer of heating, ventilation, and air conditioning (HVAC) equipment, reported earnings for Q2 2025 on August 11, 2025. The results highlighted operational
Agenus Posts 48% Q2 Revenue Miss
Agenus (NASDAQ:AGEN), a clinical-stage biotechnology company focused on developing cancer immunotherapies, reported its second quarter 2025 earnings on August 11, 2025. The company's revenue (GAAP)
If You'd Invested $1,000 in Ethereum (ETH) 10 Years Ago, Here's How Much You'd Have Today
The Ethereum (CRYPTO: ETH) blockchain went live 10 years ago. If you'd invested $1,000 in Ethereum at that time when it was trading at $2.79, you could have bought about 358 ETH tokens. Your
Late to Retirement Planning? 4 Strategies to Help You Catch Up to Your Peers
If you're late to retirement planning, beating yourself up about it accomplishes nothing. As someone who's had to start over more than once, I'm here to tell you that it's possible, and the further
Village Farms Sales Jump 12 Percent
Village Farms International (NASDAQ:VFF), a diversified greenhouse grower and international cannabis producer, reported GAAP results for Q2 2025 on August 11, 2025. The company posted GAAP earnings
Kymera Revenue Drops 55 Percent in Q2
Kymera Therapeutics (NASDAQ:KYMR), a biotechnology company recognized for its targeted protein degradation technology, released its second quarter 2025 results on August 11, 2025. The most notable
Immunovant Posts 34% R&D Jump in Q1
Immunovant (NASDAQ:IMVT), a clinical-stage biotechnology company focused on therapies for autoimmune conditions, reported results for the quarter ended June 30, 2025, on August 11, 2025. Net loss
Humacyte Posts Q2 Revenue Miss
Humacyte (NASDAQ:HUMA), a regenerative medicine company focused on bioengineered human tissues, released its Q2 FY2025 earnings on August 11, 2025. The most notable news from the release was the
Intermex Posts Mixed Results in Q2
International Money Express (NASDAQ:IMXI), a leading provider of money transfer services primarily between the United States and Latin America, reported results for Q2 2025 on August 11, 2025. The
AMC Posts 36 Percent Revenue Jump in Q2
AMC Entertainment (NYSE:AMC), a leading movie theater operator, released its second quarter 2025 earnings on August 11, 2025. The company delivered a strong recovery, reporting GAAP revenue of
Better Artificial Intelligence Stock: ASML vs. AMD
Artificial intelligence (AI) remains a hot area to invest in, as seen in Nvidia's share price, which is up over 30% this year through Aug. 6. Two AI businesses to consider are ASML Holding (NASDAQ:
Harvard Bioscience Tops Q2 Revenue Views
Harvard Bioscience (NASDAQ:HBIO), a provider of specialized laboratory technologies for biomedical and life sciences research, released its financial results for the second quarter of fiscal 2025 on
Compass Therapeutics Posts Wider Q2 Loss
Compass Therapeutics (NASDAQ:CMPX), a clinical-stage biotechnology company focused on developing novel bispecific antibody therapies for cancer, released its second quarter results on August 11
1 Reason to Buy Berkshire Hathaway (BRK.A) Stock
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is one of the world's largest and most successful companies. Led by visionary investor and CEO Warren Buffett since 1965, the investment conglomerate
Excelerate Energy EPS Jumps 31 Percent
Excelerate Energy (NYSE:EE), a leading provider of Floating Storage and Regasification Units (FSRUs) and integrated LNG solutions, released its earnings for the second quarter of fiscal 2025 on
Owens and Minor Misses Fiscal Q2 Targets
Owens & Minor (NYSE:OMI), a leading health care logistics and home health product distribution provider, reported its second quarter 2025 earnings on August 11, 2025. The most notable news was the
1 Reason to Buy EPR Properties (EPR)
EPR Properties (NYSE: EPR) is a real estate investment trust, or REIT, that focuses exclusively on experiential properties. In its portfolio of more than 300 properties are movie theaters, "eat and
The SEC Wants to Supercharge Super-Apps. Here's What Investors Need to Know
Paul Atkins, chairman of the Securities and Exchange Commission (SEC), has unveiled a host of new initiatives under the umbrella of Project Crypto. He says he wants to modernize the SEC's rules and